Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
| WBGSX Fund | USD 12.41 0.23 1.89% |
Slightly above 56% of William Blair's investor base is looking to short. The analysis of overall sentiment of trading William Blair Growth mutual fund suggests that many investors are alarmed at this time. William Blair's investing sentiment can be driven by a variety of factors including economic data, William Blair's earnings reports, geopolitical events, and overall market trends.
William |
DUBLIN, August 23, 2023 Horizon Therapeutics plc today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company. Rare disease patient groups who worked with Horizon also ranked the company first in 10 of the 14 indicators including patient centricity, patient information, integrity, access to medicines, relationships and services bey
Read at finance.yahoo.com
 |
William Blair Fundamental Analysis
We analyze William Blair's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of William Blair using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of William Blair based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
William Blair is currently under evaluation in price to sales among similar funds. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
William Blair Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with William Blair mutual fund to make a market-neutral strategy. Peer analysis of William Blair could also be used in its relative valuation, which is a method of valuing William Blair by comparing valuation metrics with similar companies.
Peers
William Blair Related Equities
| VALLX | Value Line | 2.74 | ||||
| HRSCX | Eagle Small | 0.92 | ||||
| WBIGX | William Blair | 0.51 | ||||
| WBSNX | William Blair | 0.21 | ||||
| MGOYX | Victory Munder | 0.20 |
Other Information on Investing in William Mutual Fund
William Blair financial ratios help investors to determine whether William Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in William with respect to the benefits of owning William Blair security.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |